© 2017

Nanomedicine for Cancer Therapy

From Chemotherapeutic to Hyperthermia-Based Therapy


Part of the SpringerBriefs in Applied Sciences and Technology book series (BRIEFSAPPLSCIENCES)

Also part of the Nanotheranostics book sub series (BRIEFSNANO)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Piyush Kumar, Rohit Srivastava
    Pages 1-68

About this book


This Brief focuses on the cancer therapy available till date, from conventional drug delivery to nanomedicine in clinical trial. In addition, it reports on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chosen as the model system in this review. The authors give emphasis to multiple drug resistance (MDR) and its mechanism and how to overcome it using the nanoparticle approach. 


Drug delivery for cancer Cancer theranostic agent Therapeutic diagnosis Breast cancer Multiple drug resistance

Authors and affiliations

  1. 1.Indian Institute of Technology Bombay MumbaiIndia
  2. 2.Dept of Biosci Bioengg, Rm 505Indian Inst of Tech Bombay Dept of Biosci Bioengg, Rm 505MumbaiIndia

Bibliographic information

Industry Sectors
Oil, Gas & Geosciences


“The book is informative for graduate students interested in the field of cancer therapy, for researchers working in the medical and biological sciences and for any scientists who are interested in nanomedicine. It represents very helpful small book providing an overview of conventional cancer therapies comparing them to nanomedicine based modern-day tumor therapy. It should not be missed in all biomedical research laboratories interested in modern approaches to cancer therapy.” (Cestmir Altaner, Neoplasma, Vol. 64 (2), 2017)